• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VR1

VECTION TECHNOLOGIES LTD - News & Media

12.2% ! 3.6¢
Market Cap $63.66M  !
Technology Software - Application
Add to My Watchlist

Vection Technologies Ltd (ASX:VR1) is a multinational software company that focuses on... Vection Technologies Ltd (ASX:VR1) is a multinational software company that focuses on real-time technologies for industrial companies’ digital transformation, with a strong focus on Industry with its unique Virtual Reality, Software and dedicated SaaS model approach. VR1 is set to be a leader in the Software space.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Vection inks defence contract over $7M. So why are shares down?

Vection Technologies (ASX:VR1) has announced its receipt of a A$7.1M defence contract extension @for a European client” @ but defying a recent surge for defence-facing stocks, shares were down heading into the second hour of Tuesday trades.VR1 has long offered VR training pr...

2 days ago

Vection scores $4M defence contract for AI software

Vection Technologies Ltd has scored another contract in the defence sector, following on from previous ones with the same client

05 Feb 2025 10:46 (AEDT)

'Digital human' player Vection drops -3.5% as AI-based US hospital trial kicks off

Vection has seen its shares drop -3.45% in early lunchtime trades despite launching a Massachusetts General Hospital-based AI trial.

17 Dec 2024 13:47 (AEDT)

Vection Technologies (ASX:VR1) lands major $1m defence pilot order

Vection Technologies (ASX:VR1), an enterprise-focused company bridging physical and digital worlds for clients, was awarded a major defence pilot order of $1 million for a top ten largest defence contractor in the world.

02 Mar 2023 10:45 (AEDT)

Vection Technologies (ASX:VR1) to land on the moon through new partnership

Vection Technologies (ASX:VR1) has entered into a partnership to develop a virtual reality platform that aims to take the public to space.

25 Jan 2023 12:58 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
3.6¢ 		Change
-0.005(12.2%) 		Mkt cap ! $63.66M
Open High Low Value Volume
4.0¢ 4.1¢ 3.5¢ $1.402M 36.86M

Buyers (Bids)

No. Vol. Price($)
3 1713519 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 966000 2
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
Last
3.6¢ 		  Change
-0.005 ( 12.2 %)
Open High Low Volume
4.0¢ 4.1¢ 3.5¢ 25248877
Last updated 15.58pm 30/07/2025 ?
VR1 (ASX) Chart

Top Stories

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.